NM_001101426.4:c.55A>C
Variant summary
The NM_001101426.4(CRPPA):c.55A>C (p.Ser19Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.304 (AC=394,087) in the gnomAD database across 1,297,340 control chromosomes, including 60,694 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.378. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_001101426.4 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- myopathy caused by variation in CRPPAInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2UInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy without intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_benign. The variant received -5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| B1High frequency in general population | GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.378 — exceeds 1% threshold (B1 applied) | ||
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_001101426.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CRPPA | MANE Select | c.55A>C p.Ser19Arg | missense | Exon 1 of 10 | Prot: NP_001094896.1 UniProt: | |
CRPPA | c.55A>C p.Ser19Arg | missense | Exon 1 of 9 | Prot: NP_001355126.1 | ||
CRPPA | c.55A>C p.Ser19Arg | missense | Exon 1 of 9 | Prot: NP_001094887.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CRPPA | TSL:5MANE Select | c.55A>C p.Ser19Arg | missense | Exon 1 of 10 | Prot: ENSP00000385478.2 UniProt: | |
CRPPA | TSL:1 | c.55A>C p.Ser19Arg | missense | Exon 1 of 9 | Prot: ENSP00000382249.3 UniProt: | |
CRPPA | c.55A>C p.Ser19Arg | missense | Exon 1 of 8 | Prot: ENSP00000526585.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.299 | AC:45300 | Hom:6873 | AN:151428 | Cov:33 |
GnomAD2 exomes | AF: 0.257 | AC:3585 | AN:13926 | ||
GnomAD4 exome | AF: 0.304 | AC:348776 | Hom:53827 | AN:1145802 | Cov:34 |
GnomAD4 genome | AF: 0.299 | AC:45311 | Hom:6867 | AN:151538 | Cov:33 |
TOPMed (Bravo) | AF: 0.296 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.212 | AC:7251 | Hom:1070 | AN:34150 | |
Local & regional cohorts 10 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.291 | AC:682 | Hom:92 | AN:2342 | |
ChinaMAP Phase 1 | AF: 0.304 | ||||
Denmark Genome | AF: 0.317 | AC:95 | AN:300 | ||
GenomeAsia100K | AF: 0.337 | AC:1170 | AN:3464 | ||
Korea4K (4,157 Koreans) | AF: 0.275 | AC:1972 | AN:7174 | ||
Qatari Genome | AF: 0.295 | AC:52 | AN:176 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.277 | AC:33747 | Hom:4753 | AN:121754 | |
Turkish Variome | AF: 0.276 | AC:426 | Hom:66 | AN:1546 | |
UK10K | AF: 0.318 | AC:2406 | AN:7562 | ||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.292 | AC:2618 | Hom:372 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
SCHEMA | 0.330 | 39170 | 118816 | 0.346 | 62020 | 179310 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Benign | 5.2 | |
AlphaMissense | Benign | 0.095 | |
BayesDel_addAF | Benign | -0.59 | T |
BayesDel_noAF | Benign | -0.47 | |
CADD | Benign | 3.4 | |
DANN | Benign | 0.79 | |
DEOGEN2 | Benign | 0.0014 | T |
Eigen | Benign | -1.3 | |
Eigen_PC | Benign | -1.4 | |
FATHMM_MKL | Benign | 0.062 | N |
FuncVEP CTI | Benign | 0.0019 | |
GPN-Star LLR | N/A | -1.1 | |
GPN-Star score | N/A | 1.1 | |
LIST_S2 | Benign | 0.48 | T |
MetaRNN | Benign | 0.0037 | T |
MetaSVM | Benign | -1.1 | T |
Mutation Taster | N/A | 100/0 | polymorphism (auto) |
MutationAssessor | Benign | 0.0 | N |
PhyloP100 | Benign | -1.7 | |
popEVE | Benign | -3.0 | |
PrimateAI | Uncertain | 0.75 | T |
PromoterAI | N/A | 0.12 | Neutral |
PROVEAN | Benign | -0.20 | N |
REVEL | Benign | 0.14 | |
Sift | Benign | 0.88 | T |
Sift4G | Benign | 0.66 | T |
Varity_R | N/A | 0.046 | |
VESM-3B | Benign | -2.4 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.